Malignant neoplasm of extrahepatic bile duct
ICD-10 C24.0 is a billable code used to indicate a diagnosis of malignant neoplasm of extrahepatic bile duct.
Malignant neoplasm of the extrahepatic bile duct refers to cancer that originates in the bile ducts outside the liver. These ducts are responsible for transporting bile from the liver to the gallbladder and small intestine. The most common type of cancer affecting the extrahepatic bile duct is cholangiocarcinoma, which can arise from the epithelial cells lining the bile ducts. Symptoms often include jaundice, abdominal pain, weight loss, and changes in stool color. Diagnosis typically involves imaging studies such as ultrasound, CT scans, or MRIs, which can reveal bile duct obstruction or mass lesions. Surgical resection is the primary treatment for localized tumors, but many patients present with advanced disease, making surgical intervention challenging. The prognosis is generally poor, with a five-year survival rate significantly lower than for many other cancers, underscoring the importance of early detection and intervention.
Detailed pathology reports, imaging studies, and treatment plans.
Diagnosis confirmation, treatment planning, and follow-up care.
Ensure accurate staging and documentation of tumor size and location.
Endoscopic findings, imaging results, and biopsy reports.
Evaluation of jaundice, biliary obstruction, and abnormal liver function tests.
Document any interventions performed, such as ERCP or stenting.
Used when a patient with suspected bile duct obstruction undergoes surgery.
Document indications for surgery, findings during exploration, and any interventions performed.
Ensure that the surgical notes clearly indicate the findings and any malignancy identified.
Common symptoms include jaundice, abdominal pain, weight loss, dark urine, and pale stools. Patients may also experience itching and changes in appetite.
